13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 61 holding rows worth $383,538,000.
- Accession
- 0001633055-21-000004
- Filer
- CIK 1633055
- Filed
- 2021-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 61 entries on the cover page, a total value of $383,538,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $383,538,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 396,162 | $19,313,000 | thousands by filing date | |
| INVACARE CORP | 461203AJ0 | NOTE 5.000%11/1 | 19,966,000 | $19,311,000 | thousands by filing date | |
| ACTINIUM PHARMACEUTICALS | 00507W206 | COM | 2,000,000 | $15,240,000 | thousands by filing date | call |
| Bristol-Myers Squibb Company | 110122108 | COM | 233,898 | $14,766,000 | thousands by filing date | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 399,730 | $14,694,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 272,218 | $13,464,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 54,355 | $13,216,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 167,362 | $12,591,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 238,099 | $11,838,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 45,224 | $11,533,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 455,385 | $11,476,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 31,798 | $11,414,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 133,801 | $10,958,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 310,649 | $9,835,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 87,982 | $9,521,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 709,360 | $8,952,000 | thousands by filing date | |
| INVACARE CORP | 461203101 | COMMON STOCK | 1,107,112 | $8,879,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 44,132 | $8,608,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 14,784 | $8,444,000 | thousands by filing date | |
| ELUTIA INC | 05479K106 | CL A COM | 583,600 | $8,065,000 | thousands by filing date | |
| SYNEOS HEALTH INC | 87166B102 | CL A | 105,521 | $8,004,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 2,163,518 | $7,486,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 62,722 | $7,406,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 438,933 | $7,203,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 241,016 | $6,973,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 158,702 | $6,134,000 | thousands by filing date | |
| DARIOHEALTH CORP | 23725P209 | COM | 317,876 | $6,122,000 | thousands by filing date | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 136,480 | $5,325,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 478,374 | $5,138,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 76,551 | $4,892,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 915,711 | $4,862,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 28,854 | $4,742,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,339,835 | $4,515,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 132,422 | $4,510,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 911,706 | $4,125,000 | thousands by filing date | |
| CALLIDITAS THERAPEUTICS AB SPONSERED | 13124Q106 | ADS | 142,323 | $3,923,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K200 | COM NEW | 2,376,557 | $3,707,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 103,175 | $3,637,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 229,767 | $3,217,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 517,472 | $3,092,000 | thousands by filing date | |
| SEELOS THERAPEUTICS INC | 81577F109 | COM | 611,624 | $3,052,000 | thousands by filing date | |
| ANGIODYNAMICS INC | 03475V101 | COM | 128,865 | $3,015,000 | thousands by filing date | |
| ZOETIS INC CL A | 98978V103 | Stock | 17,668 | $2,782,000 | thousands by filing date | |
| R1 RCM INC | 749397105 | COM | 108,246 | $2,672,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 330,665 | $2,616,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 23,930 | $2,579,000 | thousands by filing date | |
| ACCENDRA HEALTH INC | 690732102 | COM | 64,012 | $2,406,000 | thousands by filing date | |
| GEMINI THERAPEUTICS INC | 36870G105 | CMN | 169,876 | $2,302,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 131,796 | $2,101,000 | thousands by filing date | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 58,168 | $2,073,000 | thousands by filing date | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 15,139 | $1,681,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 55,540 | $1,558,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 151,996 | $1,309,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 313,835 | $1,205,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 13,432 | $1,107,000 | thousands by filing date | |
| FORTE BIOSCIENCES INC | 34962G109 | COM | 27,591 | $946,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 6,442 | $899,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 388,417 | $796,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 17,777 | $585,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 14,143 | $456,000 | thousands by filing date | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 16,327 | $267,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-21-000004 | this filing | 2021-05-17 | acceptance time not in the bulk data set |